Lecture 4: Cost Principles and Methods Notes

Foundations of Cost Analysis in Decision Modeling

  • Primary Objective: Include “resource consumption” + “cost offsets” into healthcare decisions to calculate the Incremental Cost-Effectiveness Ratio:   ICER=CA−CBEA−EB\text{ICER} = \frac{C_A - C_B}{E_A - E_B}   

    • CAC_A and CBC_B = costs of treatments A and B

    • EAE_A and EBE_B = respective health effects of the costs

      • Two Components:

        • Resource Consumption: Resources used during or as a result of an intervention

        • Cost Offset: resources saved/future healthcare costs avoided resulting from healthcare intervention

    • ICER/Cost-Effectiveness Analyses Purpose: compare the costs & health benefits of one medical treatment or technology vs. another

      • Cost is typically a measure of resource consumption in decision modeling

Costs as model inputs
  • Economic Definition of Cost:

    • Resource Cost: value of what we are willing to give up to acquire a resource

      • Opportunity Cost: The value of the best alternative foregone to acquire a resource

        • Conditions: Heterogeneity: different people face different costs when they choose to do the same thing.

          • Individuals have preferences

          • Individuals value time differently

          • Influenced by environment

    • Market Prices vs. Opportunity Costs: Market prices equal/reflect opportunity costs only under perfect competition.

      • Perfect Competition Where Market Price = Opportunity Cost

        • There are many buyers and sellers in the market

        • Buyers are fully informed about product characteristics

        • Price is based on agreement between a willing buyer and a willing seller (“transaction”)

        • Information about prices is widely available


      • Healthcare markets are imperfect due to:

        • 1) Intermediary agents

        • 2) Price information unavailable

        • 3) Minimal price negotiation

        • 4) Price subsidies to buyers

          • Perfect Competition: market prices (value assigned to goods/services in trade) = opportunity costs

            • AKA: prices are set entirely by supply and demand without any artificial distortions (price opacity, subsidy, taxes…).

  • Cost Evaluation Criteria:

    • Objectives: reliability (precision in estimating costs), reproducibility (others can follow approach), and validity (credibility of findings).

    • Cost Estimation Steps: *Before Estimating Costs: Decide on a Perspective”

      1. Identification: Define relevant consumed resources

      2. Quantification: Measure resource quantities

      3. Valuation: Assign monetary values to quantified resources

  • Cost Evaluation Perspectives

    • Patient

    • Payer

    • Health System

    • Society

Analytical Perspectives and Reference Cases

  • Perspective Selection: Determines which cost types are included based on the decision-maker (e.g., patient, third-party payer, health system, society). Context of the research question (and data) informs perspective choice.

  • Second Panel Recommendations: The Second Panel on Cost-Effectiveness in Health and Medicine (2016) recommends reporting two reference case perspectives:

    • Healthcare Sector Perspective: Captures all formal healthcare sector costs regardless of who pays.

    • Societal Perspective: Captures formal healthcare, informal healthcare, and non-healthcare sector costs.

Cost components included in recommended reference case perspectives
  • IMPORTANT, Cost Categorization:

    • Formal Health Care Sector: Third-party payer costs (ex: insurance) and patient out-of-pocket costs.

    • Informal Health Care Sector: Patient time, unpaid caregiver time, and transportation costs.

    • Non-Health Care Sector: Productivity losses (lost wages), consumption changes, social services, legal/criminal justice, education, housing, and environmental impacts.

Cost Measurement and Valuation Methods

  • Resource Identification: Via clinical pathway look at everything that happens to a patient during their healthcare journey, and identify what costs might arise at each stage.

    • Assign Resource Category to each event in pathway


  • Cost Precision Levels:

Levels of precision in hospital costing
  • Micro-Costing: Highly precise; itemizes individual resource components (personnel time, supplies, equipment, overhead). Suitable when interventions alter care delivery processes or when specific components drive overall costs.

  • Macro-Costing (Gross Costing): Aggregates resource categories into generalized cost units (e.g., DRG payments, per diem rates, hospital stay averages). Less resource-intensive and commonly derived from national databases.

    • Valuation Principles:

  • Charges vs. Payments: Billed charges represent list prices and differ from actual payments made by insurers/patients due to contractual discounts.

  • Standard Medical Coding Frameworks:

    • CPT/HCPCS: Procedure and service codes (e.g., 9921499214 for an established outpatient visit).

    • ICD-10: Diagnostic codes for diseases (e.g., J11.1J11.1 for influenza).

    • DRG: Inpatient prospective payment classification groups (e.g., DRG 194194 for pneumonia).

  • National Data Sources: Includes HCUPnet, Medicare Physician Fee Schedule (CMS), Medical Expenditure Panel Survey (MEPS), Red Book, Federal Supply Schedule, and claims databases.

Adjusting Costs for Time: Inflation and Discounting

  • Inflation Adjustment: Converts historical cost measurements to a baseline comparison year.

    • Personal Health Care (PHC) Expenditure Deflator: Recommended by the Second Panel over general Consumer Price Index (CPI) for healthcare service cost adjustments:     CostTarget Year=PHCTarget YearPHCBase Year×CostBase Year\text{Cost}_{\text{Target Year}} = \frac{\text{PHC}_{\text{Target Year}}}{\text{PHC}_{\text{Base Year}}} \times \text{Cost}_{\text{Base Year}}

  • Discounting: Converts future costs to present value (PV) to account for time preference and opportunity costs.

    • Recommended Discount Rate: 3%3\% annually (reflecting long-term real yield on risk-free government bonds).

    • Present Value Formula:     PV=Amt(1+r)n\text{PV} = \frac{\text{Amt}}{(1 + r)^n}     where rr is the discount rate and nn is the year in the future.

Cancer Screening Case Study Results

  • Decision Tree Model Analysis Parameters:

    • Comparison: Usual Care vs. New Screening Test.

    • Perspective: Healthcare Sector Perspective.

  • Model Results:

    • Usual Care: Expected health outcome = 9.37499.3749 life-years; Expected cost = $1,362.85\$1,362.85.

    • New Screening Test: Expected health outcome = 9.53819.5381 life-years; Expected cost = $3,136.67\$3,136.67.

    • Incremental Difference: ΔE=0.1632\Delta E = 0.1632 life-years per person; ΔC=$1,773.82\Delta C = \$1,773.82 per person (163.2163.2 life-years and $1,773,820\$1,773,820 per 1,0001,000 individuals).


  • Second Panel on Cost-Effectiveness in Health and Medicine: Helps with Perspective Building

    • Perspectives



Micro-costing (detailed costing)

  • Calculates the cost of every individual resource used.

  • Includes staff time, supplies, equipment and overheads.

  • More precise, but takes more time and effort.

  • Best when you need to know exactly where the costs come from or how a treatment changes the way care is delivered.

Example: Adding up the cost of the doctor's time, medication, tests and equipment used to treat one patient.

Macro-costing (overall costing)

  • Calculates costs using overall averages or combined costs rather than pricing every resource individually.

  • Uses figures such as the average cost per hospital stay or the cost per day in hospital.

  • Quicker and easier, often using existing databases.

  • Less detailed, so it may not show exactly what resources caused the costs.